# Abecma

NDC: 59572-515
Generic name: idecabtagene vicleucel
Labeler / Manufacturer: Celgene Corporation
Product type: CELLULAR THERAPY
Marketing category: Biologic License Application
Dosage form: SUSPENSION
Routes: INTRAVENOUS
Marketing started: 20210326

FDA application: BLA125736

## Active ingredients

- IDECABTAGENE VICLEUCEL: 300000000 1/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59572-515"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59572-515
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b90c1fe7-f5cc-464e-958a-af36e9c26d7c